BioStem Technologies (BSEM) Earnings Date, Estimates & Call Transcripts $5.96 +0.21 (+3.65%) As of 03:33 PM Eastern Add Compare Share Share Earnings Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock BioStem Technologies Earnings Summary BioStem Technologies released Q4 2024 earnings on May 12, 2025, reporting an EPS of $0.17, which missed analysts' consensus estimates of $1.25 by $1.08. Quarterly revenue was reported to be $72.53 million, below the consensus estimate of $101.20 million. With a trailing EPS of $1.14 and a P/E Ratio of 5.26, BioStem Technologies' earnings are expected to grow 62.41% next year, from $1.41 to $2.29 per share. Upcoming Earnings DateNov. 11After Market ClosesEstimatedConsensus EPS (May. 12) $1.25 Actual EPS (May. 12) $0.17 Missed By -$1.08 Actual Revenue (May. 12) $72.53MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K)BSEM Upcoming EarningsBioStem Technologies' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get BioStem Technologies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioStem Technologies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBSEM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BSEM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BioStem Technologies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$0.79$0.79$0.79Q2 20251$0.22$0.22$0.22Q3 20251$0.18$0.18$0.18Q4 20251$0.19$0.19$0.19 FY 2025 4 $1.38 $1.38 $1.38 Q1 20261$0.52$0.52$0.52Q2 20261$0.57$0.57$0.57Q3 20261$0.61$0.61$0.61 BioStem Technologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------5/12/2025Q4 2024$1.25$0.17 -$1.08$0.17$101.20M$72.53M11/12/2024-$0.31$0.32+$0.01$0.32$78.22M$82.56M8/12/2024Q2 2024$0.12$0.30+$0.18$0.30$43.99M$74.49M5/14/2024Q1 2024$0.74$0.20 -$0.54$0.20$12.70M$41.90M4/1/2024Q4 2023--$0.14--$0.14$11.40M$11.44M11/13/2023Q3 2023-$0.18$0.03+$0.21$0.03$1.39M$3.60M BioStem Technologies Earnings - Frequently Asked Questions When is BioStem Technologies' earnings date? BioStem Technologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on BSEM's earnings history. Did BioStem Technologies beat their earnings estimates last quarter? In the previous quarter, BioStem Technologies (OTCMKTS:BSEM) missed the analysts' consensus estimate of $1.25 by $1.08 with a reported earnings per share (EPS) of $0.17. Learn more on analysts' earnings estimate vs. BSEM's actual earnings. How can I listen to BioStem Technologies' earnings conference call? The conference call for BioStem Technologies' latest earnings report can be listened to online. Listen to Conference Call How can I read BioStem Technologies' conference call transcript? The conference call transcript for BioStem Technologies' latest earnings report can be read online. Read Transcript How much revenue does BioStem Technologies generate each year? BioStem Technologies (OTCMKTS:BSEM) has a recorded annual revenue of $301.83 million. What is BioStem Technologies' price-to-earnings ratio? BioStem Technologies (OTCMKTS:BSEM) has a trailing price-to-earnings ratio of 5.29 and a forward price-to-earnings ratio of 4.27. What is BioStem Technologies' EPS forecast for next year? BioStem Technologies' earnings are expected to grow from $1.41 per share to $2.29 per share in the next year, which is a 62.41% increase. More Earnings Resources from MarketBeat Related Companies Erasca Earnings Results Lexicon Pharmaceuticals Earnings Results Kamada Earnings Results Replimune Group Earnings Results REGENXBIO Earnings Results Aura Biosciences Earnings Results Absci Earnings Results Corvus Pharmaceuticals Earnings Results XOMA Royalty Earnings Results Y-mAbs Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (OTCMKTS:BSEM) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access